Search
Search Results
##search.searchResults.foundPlural##
-
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
5038PDF: 1340HTML: 1927Untitled: 194Untitled: 190 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1440HTML: 625PDF: 862 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1432PDF: 885HTML: 226 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2032PDF: 1216HTML: 790 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3657PDF: 2569HTML: 1549 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
754PDF: 477HTML: 6276 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2933PDF: 876HTML: 6598Untitled: 254Untitled: 206Untitled: 231Untitled: 236 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1333PDF: 962HTML: 93 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3711PDF: 1701HTML: 2687 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1704PDF: 532HTML: 342 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2639PDF: 822HTML: 5357 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1684PDF: 815HTML: 871jdoe, table 2 infections CML .doc: 208jdoe, table 1 infections CML .doc: 198 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1628PDF: 1075HTML: 414 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13319PDF: 997HTML: 7302 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7013PDF: 3706HTML: 808 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
2084PDF: 830HTML: 1100 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3366PDF: 1276HTML: 8386 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2251PDF: 1225HTML: 3891 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1717PDF: 817HTML: 223 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4919PDF: 2906HTML: 2325 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1339PDF: 612HTML: 3784 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1948PDF: 803HTML: 554 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5184PDF: 1550HTML: 1655Untitled: 246 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2472PDF: 975HTML: 335 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1265PDF: 619HTML: 2903ATRA induced Reactive Hemophagocytosis: A Case Report: 211 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1396PDF: 1278HTML: 512







